Aortic Aneurysm Pipeline and Clinical Trials Reviewed in new 2015 Market Research Reports

PUNE, India, October 26, 2015 /PRNewswire/ --

Aortic Aneurysm - Pipeline Review, H2 2015 and Aortic Aneurysm Global Clinical Trials Review, H1, 2015 are the new aneurysm market research reports now available in pharmaceuticals collection of RnRMarketResearch.com.

Complete report on Aortic Aneurysm pipeline H2 2015 review with 17 market data tables and 12 figures, spread across 47 pages is available at http://www.rnrmarketresearch.com/aortic-aneurysm-pipeline-review-h2-2015-market-report.html .

This report provides comprehensive information on the therapeutic development for Aortic Aneurysm, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Aortic Aneurysm and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies discussed in this report include AstraZeneca Plc, Carolus Therapeutics, Inc., Novartis AG and Vida Therapeutics Inc. Drugs Profiles discussed in this report includes BSN-908, canakinumab, CT-2009, ticagrelor, VTI-2000 Series and VTI-3000 Series. The report provides a snapshot of the global therapeutic landscape of Aortic Aneurysm and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities and also key players involved in the therapeutics development for Aortic Aneurysm and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects. A review of the Aortic Aneurysm products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages. A detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Aortic Aneurysm pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products. Order a copy of Aortic Aneurysm - Pipeline Review, H2 2015 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=424561 .

Reasons to buy this research include strategically significant competitor information, analysis, and insights available to formulate effective R&D development strategies, it helps identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Develop strategic initiatives by understanding the focus areas of leading companies, identify and understand important and diverse types of therapeutics under development for Aortic Aneurysm, plan mergers and acquisitions effectively by identifying key players of the most promising pipeline, devise corrective measures for pipeline projects by understanding Aortic Aneurysm pipeline depth and focus of Indication therapeutics, develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope as well as modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

The Aortic Aneurysm Global Clinical Trials Review, H1, 2015 market research report offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aortic Aneurysm. Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each and Listings of discontinued trials (suspended, withdrawn and terminated) is covered in this report available at http://www.rnrmarketresearch.com/aortic-aneurysm-global-clinical-trials-review-h1-2015-market-report.html .

More reports on pharmaceuticals market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .

About Us:  

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Media Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
[email protected]

SOURCE RnR Market Research

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED